Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8233316 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 5 Pages |
Abstract
A predictive model for a postimplant nomogram for prostate cancer recurrence at 9-years after PPB has been developed and validated from a large multi-institutional database. This study also demonstrates the significance of implant dosimetry for predicting outcome. Unique to predictive models, these nomograms may be used a priori to calculate a D90 that likely achieves a desired outcome with further validation. Thus, a personalized dose prescription can potentially be calculated for each patient.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Louis M.D., Mack M.D., Brian J. M.D., Ph.D., Richard G. M.D., Jay P. M.D., Michael J. M.D., Nelson N. M.D., Paul A. B.A., Changhong M.S., Katsuto M.D., Michael W. Ph.D.,